Current:Home > ContactShelley Duvall, star of "The Shining" and "Popeye," dies at 75 -Visionary Wealth Guides
Shelley Duvall, star of "The Shining" and "Popeye," dies at 75
View
Date:2025-04-16 19:38:52
Shelley Duvall, who starred in "The Shining" and worked consistently with director Robert Altman, has died at 75 years old, her partner Dan Gilroy confirmed to CBS News.
No cause of death was given but Gilroy told CBS News that Duvall was suffering a lot in the last year of her life, and said that she is now "free to fly away."
Duvall's first screen role was in the film 1970 "Brewster McCloud," which was directed by Altman. She worked with Altman again on multiple films, including "Thieves Like Us" and "Nashville," and in 1977 she took home the Cannes Film Festival Award for Best Actress for her performance in his film "3 Women."
In 1980, Duvall starred opposite Jack Nicholson in Stanley Kubrick's "The Shining," based on the Stephen King novel. In the same year, she appeared opposite Robin Williams in Altman's "Popeye," an adaptation of the beloved comic strip. Duvall continued to work consistently throughout the '80s and '90s before retiring from acting in 2002.
Duvall appeared on "Dr. Phil" in 2016, where she revealed her struggles with mental illness. The show was accused of taking advantage of her, with Kubrick's daughter Vivian calling the interview "appallingly cruel" and a "form of "lurid and exploitive entertainment."
Duvall returned to Hollywood for the 2023 horror movie "The Forest Hills." It was her last film role.
Duvall began her relationship with Gilroy in 1989, when the two co-starred on Disney Channel's "Mother Goose Rock 'n' Rhyme." The two lived in Blanco, Texas, and had no children.
- In:
- Actor Death
Kerry Breen is a news editor at CBSNews.com. A graduate of New York University's Arthur L. Carter School of Journalism, she previously worked at NBC News' TODAY Digital. She covers current events, breaking news and issues including substance use.
TwitterveryGood! (3336)
Related
- Macy's says employee who allegedly hid $150 million in expenses had no major 'impact'
- Auli’i Cravalho Reveals If She'll Return as Moana for Live-Action Remake
- EPA’s Methane Estimates for Oil and Gas Sector Under Investigation
- What is Juneteenth? Learn the history behind the federal holiday's origin and name
- Have Dry, Sensitive Skin? You Need To Add These Gentle Skincare Products to Your Routine
- Jennifer Lopez’s Contour Trick Is Perfect for Makeup Newbies
- Jessie J Gives Birth, Welcomes Baby Boy Over One Year After Miscarriage
- Nicky Hilton Shares Advice She Gave Sister Paris Hilton On Her First Year of Motherhood
- Romantasy reigns on spicy BookTok: Recommendations from the internet’s favorite genre
- Opioids are devastating Cherokee families. The tribe has a $100 million plan to heal
Ranking
- The FBI should have done more to collect intelligence before the Capitol riot, watchdog finds
- Becky Sauerbrunn, U.S. Women's National Team captain, to miss World Cup with injury
- Teen Mom's Maci Bookout Celebrates Son Bentley's Middle School Graduation
- Our Growing Food Demands Will Lead to More Corona-like Viruses
- Most popular books of the week: See what topped USA TODAY's bestselling books list
- Ranking Oil Companies by Climate Risk: Exxon Is Near the Top
- Exxon Loses Appeal to Keep Auditor Records Secret in Climate Fraud Investigation
- U.S. Appeals Court in D.C. Restores Limitations on Super-Polluting HFCs
Recommendation
McKinsey to pay $650 million after advising opioid maker on how to 'turbocharge' sales
It Ends With Us: See Brandon Sklenar and Blake Lively’s Chemistry in First Pics as Atlas and Lily
Tweeting directly from your brain (and what's next)
Climate Change Fingerprints Were All Over Europe’s Latest Heat Wave, Study Finds
Which apps offer encrypted messaging? How to switch and what to know after feds’ warning
Empty Grocery Shelves and Rotting, Wasted Vegetables: Two Sides of a Supply Chain Problem
21 Essentials For When You're On A Boat: Deck Shoes, Bikinis, Mineral Sunscreen & More
Sickle cell patient's success with gene editing raises hopes and questions